Results 221 to 230 of about 112,672 (261)

Bivalirudin in percutaneous coronary intervention

American Journal of Health-System Pharmacy, 2003
The chemistry and pharmacology, pharmacokinetics, pharmacodynamics, adverse effects, drug interactions, dosing and administration, and pharmacoeconomics of bivalirudin are reviewed; clinical trials of bivalirudin's application in percutaneous coronary intervention (PCI) are also discussed.
Michael F, Caron, George R, McKendall
openaire   +2 more sources

Percutaneous coronary intervention in the elderly

Nature Reviews Cardiology, 2010
In contemporary practice, more than one in five patients treated with percutaneous coronary intervention (PCI) are aged ≥75 years and the proportion of elderly individuals in the population is growing. The elderly have more cardiovascular risk factors and a greater burden of ischemic disease than younger patients needing PCI and, therefore, derive ...
Tracy Y, Wang, Antonio, Gutierrez, Eric D, Peterson   +2 more
openaire   +2 more sources

Percutaneous coronary intervention in the elderly

International Journal of Cardiology, 2015
Our population dynamics are changing. The number of octogenarians and older people in the general population is increasing and therefore the number of older patients presenting with acute coronary syndrome or stable angina is increasing. This group has a larger burden of coronary disease and also a greater number of concomitant comorbidities when ...
Kully, Sandhu, Sunil K, Nadar
openaire   +2 more sources

Advances in percutaneous coronary intervention

Current Cardiology Reports, 2009
Initially developed more than 30 years ago as simple balloon-based dilatation for focal coronary stenoses, the introduction of the coronary stent allowed percutaneous coronary intervention (PCI) to be applied to most patients with coronary artery disease.
Somjot S, Brar, Gregg W, Stone
openaire   +2 more sources

Complications of percutaneous coronary intervention

Progress in Cardiovascular Diseases
Complications of percutaneous coronary intervention (PCI) can lead to significant morbidity and mortality. In-depth understanding of the mechanisms and management options of these complications as well as timely recognition and action can sometimes be lifesaving. In this review we discuss the mechanisms, prevention methods, diagnosis, and management of
Ahmed, Al-Ogaili, Gauravpal S, Gill, Emmanouil S, Brilakis   +2 more
openaire   +2 more sources

Tachyarrhythmias in percutaneous coronary interventions

Journal of Electrocardiology, 2006
Accompanying the clear benefits, there are certain risks of tachyarrhythmias in percutaneous coronary interventions (PCI), including serious ventricular arrhythmias and atrial fibrillation (AF). Ventricular arrhythmias may result from excess catheter manipulation, intracoronary dye injection, new ischemic events, or reperfusion.
openaire   +3 more sources

Is facilitated percutaneous coronary intervention superior to primary percutaneous coronary intervention?

Nature Clinical Practice Cardiovascular Medicine, 2006
Is facilitated percutaneous coronary intervention superior to primary percutaneous coronary intervention?
openaire   +2 more sources

Percutaneous Coronary Intervention

2016
There are over one million percutaneous coronary interventions (PCI) performed each year in the United States. PCI refers to catheter- based procedures that allow for improved perfusion through epicardial coronary arteries to the myocardium. PCI originally referred to percutaneous transluminal coronary angioplasty, a solely balloon-based procedure, but
Yousef Bader, Manny C. Katsetos, Carey Kimmelstiel   +2 more
openaire   +1 more source

Primary Percutaneous Coronary Intervention

New England Journal of Medicine, 2008
Roger, Kapoor, John R, Kapoor
openaire   +2 more sources

Sex and percutaneous coronary intervention

The Lancet, 2013
Christiansen, Evald Høj, Jensen, Lisette Okkels   +1 more
openaire   +2 more sources